The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Open accessAbstract
The Hippo signalling pathway is an emerging growth control and tumour suppressor pathway that regulates cell proliferation and stem cell functions. Defects in Hippo signalling and hyperactivation of its downstream effectors Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) contribute to the development of cancer, which suggests that pharmacological inhibition of YAP and TAZ activity may be an effective anticancer strategy. Conversely, YAP and TAZ can also have beneficial roles in stimulating tissue repair and regeneration following injury, so their activation may be therapeutically useful in these contexts. A complex network of intracellular and extracellular signalling pathways that modulate YAP and TAZ activities have recently been identified. Here, we review the regulation of the Hippo signalling pathway, its functions in normal homeostasis and disease, and recent progress in the identification of small-molecule pathway modulators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–226 of 226
Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming
Qin, H., Blaschke, K., Wei, G., Ohi, Y., Blouin, L., Qi, Z., Yu, J., Yeh, R., Hebrok, M., & Ramalho‐Santos, M. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds023 · Cited by 92
Magic but treatable? Tumours due to loss of Merlin
Hanemann, C. O. (2007) · Brain · doi:10.1093/brain/awm249 · Cited by 91
Diep, C. H., Zucker, K. M., Hostetter, G. H., Watanabe, A. T., Hu, C., Muñoz, R. M., Hoff, D. D. V., & Han, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032783 · Cited by 88
Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma
Huo, X., Zhang, Q., Liu, A. M., Tang, C., Gong, Y., Bian, J., Luk, J. M., Xu, Z., & Chen, J. (2012) · Oncology Reports · doi:10.3892/or.2012.2176 · Cited by 87
Structural approaches to obtain kinase selectivity
Norman, R. A., Toader, D., & Ferguson, A. D. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.005 · Cited by 86
TEAD4 establishes the energy homeostasis essential for blastocoel formation
Kaneko, K. J., & Depamphilis, M. (2013) · Development · doi:10.1242/dev.093799 · Cited by 86
Anand, R., Maksimoska, J., Pagano, N., Wong, E., Gimotty, P. A., Diamond, S. L., Meggers, E., & Marmorstein, R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8005806 · Cited by 78
Mask Is Required for the Activity of the Hippo Pathway Effector Yki/YAP
Sansores-García, L., Atkins, M., Moya, I. M., Shahmoradgoli, M., Tao, C., Mills, G. B., & Halder, G. A. (2013) · Current Biology · doi:10.1016/j.cub.2012.12.033 · Cited by 73
Self-citationWbp2 cooperates with Yorkie to drive tissue growth downstream of the Salvador–Warts–Hippo pathway
Zhang, X., Milton, C. C., Poon, C. L. C., Hong, W., & Harvey, K. F. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.6 · Cited by 73
Juric, V., Chen, C.-C., & Lau, L. F. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00064-09 · Cited by 70
Homeodomain-Interacting Protein Kinase Regulates Hippo Pathway-Dependent Tissue Growth
Poon, C. L. C., Zhang, X., Lin, J. I., Manning, S. A., & Harvey, K. F. (2012) · Current Biology · doi:10.1016/j.cub.2012.06.075 · Cited by 70
Huang, H.-L., Wang, S., Yin, M.-X., Dong, L., Wang, C., Wu, W., Lu, Y., Feng, M., Dai, C.-Y., Guo, X., et al. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001620 · Cited by 68
Mask Proteins Are Cofactors of Yorkie/YAP in the Hippo Pathway
Sidor, C., Brain, R., & Thompson, B. J. (2013) · Current Biology · doi:10.1016/j.cub.2012.11.061 · Cited by 67
Zhao, M., Szafrański, P., Hall, C. A., & Goode, S. (2008) · Genetics · doi:10.1534/genetics.108.086983 · Cited by 66
Crumbs proteins in epithelial morphogenesis
Bazellières, E., Assémat, E., Arsanto, J.-P., Bivic, A. L., & Massey‐Harroche, D. (2009) · Frontiers in bioscience · doi:10.2741/3368 · Cited by 64
Cadherin mechanotransduction in tissue remodeling
Twiss, F., & de Rooij, J. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1329-x · Cited by 64
Homeodomain-Interacting Protein Kinase Regulates Yorkie Activity to Promote Tissue Growth
Chen, J., & Verheyen, E. M. (2012) · Current Biology · doi:10.1016/j.cub.2012.06.074 · Cited by 60
Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73
Kawahara, M., Hori, T., Chonabayashi, K., Oka, T., Sudol, M., & Uchiyama, T. (2008) · Blood · doi:10.1182/blood-2007-09-111773 · Cited by 56
Quit your YAPing: a new target for cancer therapy: Figure 1.Preprint
Stanger, B. Z. (2012) · Genes & Development · doi:10.1101/gad.196501.112 · Cited by 55
MacDougall, N., Lad, Y., Wilkie, G. S., Francis-Lang, H., Sullivan, W., & Davis, I. (2001) · Development · doi:10.1242/dev.128.5.665 · Cited by 55
N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability
Yabuta, N., Mukai, S., Okamoto, A., Okuzaki, D., Suzuki, H., Torigata, K., Yoshida, K., Okada, N., Miura, D., Ito, A., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.113431 · Cited by 46
Milton, C. C., Zhang, X., Albanese, N. O., & Harvey, K. F. (2010) · Development · doi:10.1242/dev.042309 · Cited by 36
Zhu, J. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.543 · Cited by 32
An update on targeting Hippo-YAP signaling in liver cancer
Liu, A. M., Xu, Z., & Luk, J. M. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.662958 · Cited by 32
Intestinal Regeneration: YAP—Tumor Suppressor and Oncoprotein?
Li, V. S. W., & Clevers, H. C. (2013) · Current Biology · doi:10.1016/j.cub.2012.12.021 · Cited by 20
N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability
Yabuta, N., Mukai, S., Okamoto, A., Okuzaki, D., Suzuki, H., Torigata, K., Yoshida, K., Okada, N., Miura, D., Ito, A., et al. (2013) · Development · doi:10.1242/dev.096842 · Cited by 18
Cited by
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
The Cancer Genome Atlas Research Network (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505917 · Cited by 1,336
The emerging roles of YAP and TAZ in cancer
Moroishi, T., Hansen, C. G., & Guan, K.-L. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3876 · Cited by 1,145
Emerging Mechanisms and Disease Relevance of Ferroptosis
Stockwell, B. R., Jiang, X., & Gu, W. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.02.009 · Cited by 1,099
YAP/TAZ upstream signals and downstream responses
Totaro, A., Panciera, T., & Piccolo, S. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0142-z · Cited by 1,086
Hippo–YAP/TAZ signalling in organ regeneration and regenerative medicine
Moya, I. M., & Halder, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0086-y · Cited by 981
Self-citation
Metadata
- Authors
- Johnson, R., & Halder, G.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2013-12-13
- Volume
- 13
- Issue
- 1
- Pages
- 63-79
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1996690536
- Cited by
- 881
- References
- 226
- FWCI
- 6.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.